Reza Malekzadeh
Reza Malekzadeh is an expert in Gastroenterology at Shariati Hospital (Iran). As of October 2026, ScienceLeadR ranks Reza Malekzadeh in the top 1% of experts worldwide for Esophageal Neoplasms and Esophageal Diseases, and in the top 1% of experts in Iran for Gastroesophageal Reflux. Reza Malekzadeh has authored 1,246 publications, the most recent in 2026, and is an investigator in 29 clinical trials. SLR score: 4,175 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties: Public Health - Oncology - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1982 - 2026
Number : 1246
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Dietary intake of vitamins B1, B2, B3, and B6, and the risk of gastric cancer: pooled analyses within the Stomach cancer Pooling (Stop) project. PMID 42841975 — cardia, stomach, vitamins, meat, neoplasms, fruit, micronutrients, sex, vegetables, stomach neoplasms | Eur J Nutr | 2026 | 0 |
| Physical activity and oxidative stress biomarkers in humans: a systematic review and quantitative meta-analysis. PMID 42760575 — exercise, bias, stress, physiological, publication bias, oxidative stress, biomarkers, antioxidants | BMC Sports Sci Med Rehabil | 2026 | 0 |
| Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization. PMID 42755691 — liver diseases, hypertension, heart diseases, calcium channel blockers, heart failure, pharmaceutical preparations, heart, non-alcoholic fatty liver disease, blood pressure, renin, liver, antihypertensive agents, angiotensins, odds ratio, coronary disease, risk factors, therapeutics, fatty liver, random allocation, renin-angiotensin system, hemodynamics | Hypertension | 2026 | 0 |
| Tobacco and opium use and risk of liver and colorectal cancer mortality: Analysis of the Golestan Cohort Study (GCS). PMID 42671160 — mortality, opium, neoplasms, cohort studies, liver, liver neoplasms, colorectal neoplasms, smoking, pipe smoking, opium dependence | Cancer Epidemiol Biomarkers Prev | 2026 | 0 |
| Benchmarking female breast cancer survival in africa, Central and South america, and asia (SURVCAN-3). PMID 42633567 — breast neoplasms, neoplasms, breast, diagnosis, benchmarking, prognosis | J Natl Cancer Inst | 2026 | 0 |
Clinical Studies 29
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 12
LeadR Networks
Main global connection map